Brian Schwartz
Technik-/Wissenschafts-/F&E-Leiter bei INTENSITY THERAPEUTICS, INC.
Vermögen: 29 364 $ am 30.04.2024
Aktive Positionen von Brian Schwartz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 17.12.2020 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 25.01.2024 | - | |
| Independent Dir/Board Member | 17.12.2020 | 25.01.2024 | |
| INTENSITY THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Brian Schwartz
Ehemalige bekannte Positionen von Brian Schwartz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 07.09.2021 | 24.07.2023 |
| MEREO BIOPHARMA GROUP PLC | Direktor/Vorstandsmitglied | 01.10.2020 | 10.11.2022 |
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 05.03.2020 | 23.12.2020 |
| Independent Dir/Board Member | 05.03.2020 | 23.12.2020 | |
| ARQULE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2008 | 01.03.2020 |
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 | - |
| General Counsel | 01.01.2008 | - |
Ausbildung von Brian Schwartz
| University of Pretoria | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Südafrika | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 5 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
- Börse
- Insiders
- Brian Schwartz
- Erfahrung
